Johnson & Johnson said ERLEADA given before and after surgery reduced the risk of recurrence or death by 62% compared with surgery alone in patients with high-risk prostate cancer. For shareholders,…
#stocks #investing
Johnson & Johnson said ERLEADA given before and after surgery reduced the risk of recurrence or death by 62% compared with surgery alone in patients with high-risk prostate cancer. For shareholders,…
#stocks #investing
https://europepharmatoday.com/news/jnj-erleada-proteus-substudy-esmo-october-2026?utm_source=bluesky&utm_medium=social&utm_campaign=jnj-erleada-proteus-substudy-esmo-october-2026
#EMA
https://europepharmatoday.com/news/jnj-erleada-proteus-substudy-esmo-october-2026?utm_source=bluesky&utm_medium=social&utm_campaign=jnj-erleada-proteus-substudy-esmo-october-2026
#EMA
..................
https://nile1.com/johnson-johnsons-erleada-prostate-cancer-result-counts-a-rising-psa-as-an-event/
..................
#androgenDeprivationTherapy #apalutamide #erleadaProstateCancer #esmo2026 #halda
..................
https://nile1.com/johnson-johnsons-erleada-prostate-cancer-result-counts-a-rising-psa-as-an-event/
..................
#androgenDeprivationTherapy #apalutamide #erleadaProstateCancer #esmo2026 #halda
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide…
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide…
https://wsnext.com/9bddf32-Corporate-valuations-Risk-management/
https://wsnext.com/9bddf32-Corporate-valuations-Risk-management/
https://www.infomoney.com.br/saude/jj-mostra-resultados-positivos-de-medicamento-para-cancer-de-prostata/?utm_source=flipboard&utm_medium=activitypub
Posted into Economia & Negócios @economia-neg-cios-FlipboardBR
https://www.infomoney.com.br/saude/jj-mostra-resultados-positivos-de-medicamento-para-cancer-de-prostata/?utm_source=flipboard&utm_medium=activitypub
Posted into Economia & Negócios @economia-neg-cios-FlipboardBR
xtandi
erleada
zytiga
xtandi
erleada
zytiga
May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved th...
May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved th...
Ein Patient mit seit Jahren gut eingestellter #Hypertonie bemerkt einen massiven Blutdruckanstieg. Ist das von ihm seit fünf Tagen eingenommene Antiandrogen Apalutamid die Ursache?
www.arznei-telegramm.com/de/6481/apal...
Ein Patient mit seit Jahren gut eingestellter #Hypertonie bemerkt einen massiven Blutdruckanstieg. Ist das von ihm seit fünf Tagen eingenommene Antiandrogen Apalutamid die Ursache?
www.arznei-telegramm.com/de/6481/apal...
1️⃣ Epidiolex® – Cannabidiol for rare epilepsy
2️⃣ Esbriet® – Antifibrotic agent for idiopathic pulmonary fibrosis
3️⃣ Erleada® – Prostate cancer therapy
Explore the clinical evidence: drugdocs.com
1️⃣ Epidiolex® – Cannabidiol for rare epilepsy
2️⃣ Esbriet® – Antifibrotic agent for idiopathic pulmonary fibrosis
3️⃣ Erleada® – Prostate cancer therapy
Explore the clinical evidence: drugdocs.com
1️⃣ Epidiolex® – Cannabidiol for rare epilepsy
2️⃣ Erleada® – Prostate cancer therapy
3️⃣ Avastin® – Anti-VEGF oncology mainstay
Explore the clinical evidence: drugdocs.com
1️⃣ Epidiolex® – Cannabidiol for rare epilepsy
2️⃣ Erleada® – Prostate cancer therapy
3️⃣ Avastin® – Anti-VEGF oncology mainstay
Explore the clinical evidence: drugdocs.com
zurl.co/31NIC
zurl.co/fzdbT
Published on Tuesday, September 16, 2025
Published on Tuesday, September 16, 2025